Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality
Authors
Keywords
Quetiapine, Olanzapine, Cardiometabolic, Mortality, Register
Journal
JOURNAL OF PSYCHIATRIC RESEARCH
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-11-09
DOI
10.1016/j.jpsychires.2021.11.023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
- (2020) Heidi Taipale et al. World Psychiatry
- Association of Tourette Syndrome and Chronic Tic Disorder With Metabolic and Cardiovascular Disorders
- (2019) Gustaf Brander et al. JAMA Neurology
- Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness
- (2019) Joseph F. Hayes et al. JAMA Psychiatry
- Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review
- (2019) Guillermo Prada-Ramallal et al. BMC Medical Research Methodology
- Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016
- (2019) Mikkel Højlund et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden
- (2019) Yasmina Molero et al. BMJ-British Medical Journal
- Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study
- (2018) Chi-Shin Wu et al. JOURNAL OF AFFECTIVE DISORDERS
- Weight change over two years in people prescribed olanzapine, quetiapine and risperidone in UK primary care: Cohort study in THIN, a UK primary care database
- (2018) David PJ Osborn et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies
- (2018) Kyle J. Burghardt et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004–2015
- (2017) Pål Gjerden et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The Swedish cause of death register
- (2017) Hannah Louise Brooke et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study
- (2016) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Role and clinical implications of atypical antipsychotics in anxiety disorders, obsessive-compulsive disorder, trauma-related, and somatic symptom disorders
- (2016) Umberto Albert et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Atypical antipsychotics for insomnia: a systematic review
- (2016) Wade Thompson et al. SLEEP MEDICINE
- Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends
- (2015) Louise Carton et al. CURRENT PHARMACEUTICAL DESIGN
- Antipsychotic Drugs and the Risk of Ventricular Arrhythmia and/or Sudden Cardiac Death: A Nation-wide Case-Crossover Study
- (2015) C.-S. Wu et al. Journal of the American Heart Association
- Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia
- (2015) Donovan T. Maust et al. JAMA Psychiatry
- Antipsychotic Treatment and Mortality in Schizophrenia
- (2014) M. Torniainen et al. SCHIZOPHRENIA BULLETIN
- Prescribing of antipsychotics in UK primary care: a cohort study
- (2014) Louise Marston et al. BMJ Open
- External review and validation of the Swedish national inpatient register
- (2011) Jonas F Ludvigsson et al. BMC PUBLIC HEALTH
- Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders
- (2011) Simon Zhornitsky et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults
- (2011) Alicia Ruelaz Maher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
- (2011) A. J. Mitchell et al. PSYCHOLOGICAL MEDICINE
- A four-year naturalistic prospective study of cardiometabolic disease in antipsychotic-treated patients
- (2010) P. Mackin et al. EUROPEAN PSYCHIATRY
- Statistically Significant Increase in Weight Caused by Low-Dose Quetiapine
- (2010) Scott G Williams et al. PHARMACOTHERAPY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
- (2009) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started